LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Clinical trials for LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less be more? new study tests lower cancer drug doses to cut side effects
Disease control Recruiting nowThis study tests whether giving a lower, less frequent dose of the cancer drug atezolizumab can still control tumors while causing fewer side effects. About 30 adults with advanced lung, liver, skin, or sarcoma cancers will receive the drug alone or with other treatments. Researc…
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 16, 2026 22:46 UTC
-
Liver cancer hope: combo therapy may boost survival after first treatment fails
Disease control Recruiting nowThis study is for people with advanced liver cancer that cannot be removed by surgery and has gotten worse after initial treatment with atezolizumab plus bevacizumab. Researchers want to see if adding another immunotherapy drug (atezolizumab) to a standard targeted therapy pill (…
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated May 16, 2026 22:43 UTC
-
Tailor-Made cancer vaccine shows promise in advanced tumors
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors. The goal is to see if this combination is safe and helps the immune system fight cancer more effectively. A…
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New combo therapy aims to shrink advanced liver tumors
Disease control Recruiting nowThis study tests whether a two-step treatment—internal radiation therapy followed by an immunotherapy drug combination—can shrink tumors better than radiation alone in people with advanced liver cancer that hasn't spread outside the liver. About 100 participants will be randomly …
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated Apr 26, 2026 19:37 UTC
-
Could a common drug fight cancer wasting?
Symptom relief Recruiting nowThis study tests if olanzapine, a drug that affects brain chemicals, can help cancer patients who have lost their appetite and weight. The trial includes 66 adults with advanced lung, stomach, or colorectal cancers who are not being treated with a goal to cure. Participants will …
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC